|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 8 of 8
Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | article (author version) | Furuta, Megumi; Sakakibara-Konishi, Jun; Kikuchi, Hajime; Yokouchi, Hiroshi; Nishihara, Hiroshi; Minemura, Hiroyuki; Harada, Masao; Yamazaki, Shigeo; Akie, Kenji; Fujita, Yuka; Takamura, Kei; Kojima, Tetsuya; Harada, Toshiyuki; Minami, Yoshinori; Watanabe, Naomi; Oizumi, Satoshi; Suzuki, Hiroyuki; Nishimura, Masaharu; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi | Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702) | - | The Oncologist | - | Nov-2019 |
article | Kikuchi, Hajime; Sakakibara-Konishi, Jun; Furuta, Megumi; Yokouchi, Hiroshi; Nishihara, Hiroshi; Yamazaki, Shigeo; Uramoto, Hidetaka; Tanaka, Fumihiro; Harada, Masao; Akie, Kenji; Sugaya, Fumiko; Fujita, Yuka; Takamura, Kei; Kojima, Tetsuya; Harada, Toshiyuki; Higuchi, Mitsunori; Honjo, Osamu; Minami, Yoshinori; Watanabe, Naomi; Oizumi, Satoshi; Suzuki, Hiroyuki; Ishida, Takashi; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Munakata, Mitsuru; Nishimura, Masaharu | Expression of Notch1 and Numb in small cell lung cancer | - | Oncotarget | - | 7-Feb-2017 |
article | Yamamoto, Gaku; Asahina, Hajime; Honjo, Osamu; Sumi, Toshiyuki; Nakamura, Atsushi; Ito, Kenichiro; Kikuchi, Hajime; Hommura, Fumihiro; Honda, Ryoichi; Yokoo, Keiki; Fujita, Yuka; Oizumi, Satoshi; Morita, Ryo; Ikezawa, Yasuyuki; Tanaka, Hisashi; Kimura, Nozomu; Sasaki, Takaaki; Sukoh, Noriaki; Takashina, Taichi; Harada, Toshiyuki; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi | First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002) | - | Scientific reports | - | 30-Nov-2021 |
article | Komatsu, Yoshito; Okita, Kenji; Yuki, Satoshi; Furuhata, Tomohisa; Fukushima, Hiraku; Masuko, Hiroyuki; Kawamoto, Yasuyuki; Isobe, Hiroshi; Miyagishima, Takuto; Sasaki, Kazuaki; Nakamura, Michio; Ohsaki, Yoshinobu; Nakajima, Junta; Tateyama, Miki; Eto, Kazunori; Minami, Shinya; Yokoyama, Ryoji; Iwanaga, Ichiro; Shibuya, Hitoshi; Kudo, Mineo; Oba, Koji; Takahashi, Yasuo | Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron | - | Cancer science | - | Jul-2015 |
article (author version) | Takashina, Taichi; Asahina, Hajime; Oizumi, Satoshi; Yamada, Noriyuki; Harada, Masao; Takamura, Kei; Yokouchi, Hiroshi; Harada, Toshiyuki; Honjo, Osamu; Ogi, Takahiro; Morikawa, Naoto; Kinoshita, Ichiro; Honda, Ryoichi; Nakano, Kosuke; Kanazawa, Kenya; Amano, Toraji; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, Masaharu | A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101) | - | International journal of clinical oncology | - | Dec-2018 |
article (author version) | Asahina, Hajime; Oizumi, Satoshi; Inoue, Akira; Kinoshita, Ichiro; Ishida, Takashi; Fujita, Yuka; Sukoh, Noriaki; Harada, Masao; Maemondo, Makoto; Saijo, Yasuo; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nukiwa, Toshihiro; Nishimura, Masaharu | Phase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib | - | Oncology : International Journal for Cancer Research and Treatment | - | Apr-2011 |
article (author version) | Asahina, Hajime; Oizumi, Satoshi; Takamura, Kei; Harada, Toshiyuki; Harada, Masao; Yokouchi, Hiroshi; Kanazawa, Kenya; Fujita, Yuka; Kojima, Tetsuya; Sugaya, Fumiko; Tanaka, Hisashi; Honda, Ryoichi; Kikuchi, Eiki; Ikari, Tomoo; Ogi, Takahiro; Shimizu, Kaoruko; Suzuki, Masaru; Konno, Satoshi; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, Masaharu | A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302) | - | Lung cancer | - | Dec-2019 |
article (author version) | Ikezawa, Yasuyuki; Asahina, Hajime; Oizumi, Satoshi; Watanabe, Masahiro; Takamura, Kei; Kawai, Yasutaka; Yamada, Noriyuki; Harada, Toshiyuki; Kinoshita, Ichiro; Fujita, Yuka; Miyauchi, Eisaku; Ogi, Takahiro; Amano, Toraji; Furuta, Megumi; Sakakibara-Konishi, Jun; Nishihara, Hiroshi; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, Masaharu | A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002) | A randomized phase II trial of erlotinib versus S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002) | Cancer chemotherapy and pharmacology | - | Nov-2017 |
Showing results 1 to 8 of 8
|